Recludix Pharma, a leader in discovery of inhibitors of challenging targets for inflammatory disease, today announced that ...

Scientists at the Garvan Institute of Medical Research have uncovered a connection between certain genetic variations and the ...

The combination of ACT001 and radiotherapy elicited responses and was considered well tolerated in a phase 2 trial of pediatric patients with newly diagnosed DIPG.

Lead researcher, Dr Aleks Guanizo explained: "We identified a cascade in which the protein STAT3 is essential to maintain the ...

In 2023, we published another article about CRSP in Cell Biology Education – A Journal of Life Science Education. That article assesses the impact of shifting research modalities and their impacts on ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Bio-Path Holdings Inc (BPTH) reports progress in clinical trials and improved financial performance despite cash reserve ...

IND cleared by FDA and dosing in the Phase 1 clinical trial initiated, with data expected in the first half of 2025 Sanofi expanding KT-474/SAR444656 (IRAK4) Phase 2 clinical trials in HS and AD to ...

Gene delivery is a process by which foreign DNA is transferred to host cells for applications such as genetic research or gene therapy. Gene delivery methods can be mechanical (e.g. microinjection ...

The following is a summary of “Allergic fungal rhinosinusitis linked to other hyper-IgE syndromes through defective TH17 ...

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...

Expands DNAbilize® Technology Beyond Oncology into ObesityConference Call to be Held Today at 8:30 A.M. ETHOUSTON, Nov. 15, 2024 (GLOBE ...